Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2011; 17(12): 1631-1641
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Published online Mar 28, 2011. doi: 10.3748/wjg.v17.i12.1631
Figure 2 Immunohistochemical detection of trefoil factor proteins in normal and dysplasia bile ducts (Original magnification × 400).
A: Small and large normal bile ducts (short arrows) showing no trefoil factor (TFF)1 expression, whereas dysplasia showed moderately increased expression (long arrows); B: TFF2 expression was strongly positive in peribiliary glands (long arrows) but rarely present in dysplasia (short arrows); C: TFF3 was distributed widely at low level in small and large normal bile ducts (short arrows) and markedly increased in dysplasia (long arrows).
- Citation: Kosriwong K, Menheniott TR, Giraud AS, Jearanaikoon P, Sripa B, Limpaiboon T. Trefoil factors: Tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma. World J Gastroenterol 2011; 17(12): 1631-1641
- URL: https://www.wjgnet.com/1007-9327/full/v17/i12/1631.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i12.1631